Zentalis Pharmaceuticals (ZNTL)
(Delayed Data from NSDQ)
$11.06 USD
+0.08 (0.68%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $11.07 +0.01 (0.09%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/08/2024
Time: -- |
3/2024 | $-0.85 | 0.00% |
Earnings Summary
For their last quarter, Zentalis Pharmaceuticals (ZNTL) reported earnings of -$0.83 per share, beating the Zacks Consensus Estimate of $-0.92 per share. This reflects a positive earnings surprise of 9.78%. Look out for ZNTL's next earnings release expected on May 08, 2024. For the next earning release, we expect the company to report earnings of -$0.85 per share, reflecting a year-over-year increase of 20.56%.
Earnings History
Price & Consensus
Zacks News for ZNTL
Down -19.06% in 4 Weeks, Here's Why You Should You Buy the Dip in Zentalis Pharmaceuticals, Inc. (ZNTL)
ZNTL: What are Zacks experts saying now?
Zacks Private Portfolio Services